Invokana belongs to a relatively new class of type 2 diabetes drugs called SGLT-2 inhibitors, which helps remove excess blood sugar through urine. The FDA just recently required Invokana to include a warning about a high risk of foot and leg amputations in diabetic patients. This change in the required warning is the result of two clinical trials that concluded that leg and foot amputations occurred about twice as often in patients with type 2 diabetes treated with Invokana, which puts a great many diabetic patients using Invokana at risk.
If you are going in for surgery, you probably have a lot on your mind. The questions come in bunches: Will the operation be successful? Will insurance pick up the bulk of the cost? How long will the recovery period be? And so on.
A close friend or family member goes into the hospital, expecting to get better. Instead, he or she gets worse and maybe even dies.